An integrative review: Application of self-efficacy instruments for walking in populations with peripheral arterial disease

Journal of Vascular Nursing

Volumn 31, Issue 3, 2013, Pages 118-130

  Caldieraro Bentley, Angela J ^a   Andrews, Jeannette O ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; INTERMITTENT CLAUDICATION; NURSING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PSYCHOMETRY; RISK FACTOR; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WALKING;

HUMANS; INTERMITTENT CLAUDICATION; PERIPHERAL ARTERIAL DISEASE; PSYCHOMETRICS; RISK FACTORS; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WALKING;

EID: 84881583659     PISSN: 10620303     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvn.2013.01.002     Document Type: Article

References (38)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Allison M.A., Ho E., Denenberg J.O., et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007, 32:328-333.
3. Alzamora M.T., Fores R., Baena-Diez J.M., et al. The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health 2010, 10:38.
4. Kannel W.B., Skinner J.J., Schwartz M.J., et al. Intermittent claudication: incidence in the Framingham Study. Circulation 1970, 41:875-883.
5. Criqui M.H., Fronek A., Barrett-Connor E., et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985, 71:510-515.
6. Hirsch A.T., Halverson S.L., Treat-Jacobson D., et al. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med 2001, 6:87-96.
7. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
8. Narins C., Wojciech Z., Moss A., et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med 2004, 164:440-446.
9. Novo S. Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes Obes Metab 2002, 4(Suppl 2):S1-S6.
10. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. Peripheral arterial disease: ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 2006, 47:1239-1312.
11. McDermott M., Greenland P., Liu K., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001, 286:1599-1606.
12. Feinglass J., McCarthy W.J., Slavensky R., et al. Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. The Chicago Claudication Outcomes Research Group. J Vasc Surg 1996, 24:503-512.
13. Olin J.W., Allie D.E., Belkin M., et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). J Am Coll Cardiol 2010, 56:2147-2181.
14. Jerome G.J., McAuley E. Enrollment and participation in a pilot walking programme: The role of self-efficacy. J Health Psychol 2013, 18:236-244.
15. Koring M., Richert J., Lippke S., et al. Synergistic effects of planning and self-efficacy on physical activity. Health Educ Behav 2012, 39:152-158.
16. Jenkins L.S., Gortner S.R. Correlates of self-efficacy expectation and prediction of walking behavior in cardiac surgery elders. Ann Behav Med 1998, 20:99-103.
17. Robertson D., Keller C. Relationships among health beliefs, self-efficacy, and exercise adherence in patients with coronary artery disease. Heart Lung 1992, 21:56-63.
18. Collins T.C., Lunos S., Ahluwalia J.S. Self-efficacy is associated with walking ability in persons with diabetes mellitus and peripheral arterial disease. Vasc Med 2010, 15:189-195.
19. Rejeski W.J., Tian L., Liao Y., et al. Social cognitive constructs and the promotion of physical activity in patients with peripheral artery disease. J Cardiopulm Rehabil Prev 2008, 28:65-72.
20. Bandura A. Social Foundations of Thought and Action 1986, Prentice-Hall, Engelwood Cliffs, NJ.
21. Mullen S.P., McAuley E., Satariano W.A., Kealey M., Prohaska T.R. Physical activity and functional limitations in older adults: the influence of self-efficacy and functional performance. J Gerontol B Psychol Sci Soc Sci 2012, 67:354-361.
22. Lee L.L., Avis M., Arthur A. The role of self-efficacy in older people's decisions to initiate and maintain regular walking as exercise-findings from a qualitative study. Prev Med 2007, 45:62-65.
23. Bandura A., Walters R. Social Learning and Personality Development 1963, Holt, Rinehart & Winston, New York.
24. Wittemore R., Knafl K. The integrative review: updated methodology. J Adv Nurs 2005, 52:546-553.
25. OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford Center of EBM 2011. Available at: Accessed October 17, 2012. http://www.cebm.net/index.aspx%3fo%3d5653.
26. Allison M.J., Keller C. Self-efficacy intervention effect on physical activity in older adults. West J Nurs Res 2004, 26:31-46.
27. Houle J., Doyon O., Vadeboncoeur N., et al. Innovative program to increase physical activity following an acute coronary syndrome: randomized controlled trial. Patient Educ Couns 2011, 85:e237-e244.
28. Perkins S., Jenkins L.S. Self-efficacy expectation, behavior performance and mood status in early recovery from percutaneous transluminal coronary angioplasty. Heart Lung 1998, 27:37-46.
29. Gary R. Exercise self-efficacy in older women with diastolic heart failure. J Gerontol Nurs 2006, 32:31-39.
30. Oka R.K., DeMarco T., Haskell W.L. Effect of treadmill testing on self-efficacy on patients with heart failure. Eur J Cardiovasc Nurs 2005, 4:215-219.
31. Bandura A. Self-efficacy. Encyclopedia of Human Behavior 1994, Academic Press, New York. 4th ed. V.S. Ramachaudren (Ed.).
32. McAuley E., Jacobson L. Self-efficacy and exercise participation in sedentary adult females. Am J Health Promot 1991, 5:185-191.
33. McAuley E. The role of self-efficacy cognitions in the prediction of exercise behavior in middle-aged adults. J Behav Med 1992, 15:65-88.
34. Kullo I.J., Bailey K.R., Kardia S.L., et al. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med 2003, 8:237-242.
35. Hirsch A.T., Allison M.A., Gomes A.S., et al. A call to action: women and peripheral artery disease. Circulation 2012, 125:1449-1472.
36. DeVon H.A., Block M.E., Moyle-Wright P., et al. A psychometric toolbox for testing validity and reliability. J Nurs Scholarship 2007, 39:155-164.
37. Jenkins L. Jenkins Instruments: Self-Efficacy Expectations and Scales and Activity Check-lists for Selected Cardiac Recovery Behaviors 1987, University of Maryland, College Park, MD.
38. Stanford Patient Education Research Center. Chronic Disease Self-Efficacy Scales. Palo Alto, CA: Stanford Patient Education Research Center; 2001.